Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.325NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.6.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.6.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.443NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.443NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.595.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.595.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.85NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.85NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.65NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.65NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.10.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.10.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.56NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.51NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.51NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XATNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XATNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used